Birmingham Bio Innovation Corporation's mission is to facilitate and promote the growth of Alabama's biotechnology ecosystem. Building on the region's existing strengths in R&D, fueled by the University of Alabama at Birmingham (the State of Alabama's largest employer) and Southern Research Institute (a translational research institution with a long history of biotech and pharmaceutical research and commercialization), BBIC will advance an innovative biotech economy that attracts and nurtures companies, creates jobs, and improves health outcomes through accelerating the development of drugs, vaccines, and diagnostics.
Main program · fiscal year 2024
The Organization partipated in various activities throughout the year for the purpose of organizing and raising funds in order to support future projects to advance an innovative biotech economy.
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$800,000Fiscal year 2024
Expenses$846,207Fiscal year 2024
Total assets$5,505,160Fiscal year 2024
Total liabilities$5,551,367Fiscal year 2024
Fiscal year ending December2024
Revenue$800,000
Expenses$846,207
Net income−$46,207
Net assets−$46,207
Notable sources of revenue
Percent of total revenue
Contributions
$800,000
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$5,505,160
Total liabilities
$5,551,367
Net assets
−$46,207
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?